New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 15, 2014
14:00 EDTCNMDCONMED receives notice of intent to nominate candidates from Voce Capital
CONMED confirmed receipt of notice from Voce Capital Management of its intention to nominate James W. Green, Alan L. Kaganov, Joshua H. Levine, Jeffrey M. Nugent, and J. Daniel Plants to stand for election to the company's Board of Directors at the 2014 Annual Meeting of Shareholders. CONMED shareholders are not required to take any action at this time. CONMED has determined to postpone the record date for its 2014 Annual Meeting of Shareholders and expects that the new record date will be announced in a future press release. Further details regarding the 2014 Annual Meeting of Shareholders, including the date, which is expected to be no later than July 31 will be included in the company's preliminary proxy statement, which will be mailed to shareholders of record in advance of the meeting. CONMED will present its formal recommendation regarding director nominations in its definitive proxy statement to be filed with the SEC and will provide shareholders with proxy materials, including a proxy card, in connection with the 2014 Annual Meeting of Shareholders in due course.
News For CNMD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 24, 2015
10:00 EDTCNMDOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:13 EDTCNMDCONMED downgraded to Neutral from Buy at Ladenburg
Subscribe for More Information
April 22, 2015
16:19 EDTCNMDCONMED sees FY15 adjusted EPS $1.82-$1.92, consensus $1.86
The company reiterated its previously disclosed constant currency sales guidance, which calls for organic sales growth in 2015 to be in the range of 1%-3%. If foreign currency exchange rates hold near current levels, the company expects net sales for the last three quarters of 2015 to be negatively impacted by $3.9M as compared to prior sales guidance, which was based on January 23 currency rates. Using current exchange rates, CONMED now anticipates that reported sales for 2015 will be in the range of $723M-$738M, consensus $732.62M.
16:18 EDTCNMDCONMED reports Q1 adjusted EPS 42c, consensus 43c
Reports Q1 revenue $177.9M, consensus $174.98M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use